Amrutanjan Health Care Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 556.05 as of 18 May 15:30 . The P/E Ratio of Amrutanjan Health Care Ltd is 0 as of December 2023 .The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 . The Market Cap of Amrutanjan Health Care Ltd is ₹ 0 crore as of December 2023 .The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 . The Revenue of Amrutanjan Health Care Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 . The EBITDA of Amrutanjan Health Care Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 . The Net Profit of Amrutanjan Health Care Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 . The Dividend Payout of Amrutanjan Health Care Ltd changed from 20.04 % on March 2021 to 0 % on December 2025 . This represents a CAGR of -100.00% over 10 yearsThe Dividend Payout of Sanofi India Ltd changed from 119.34 % on December 2021 to 86.59 % on December 2025 . This represents a CAGR of -6.21% over 5 years .

About Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu.
The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research.
Three plants have been set up in the Alandur industrial belt near Chennai to produce these products.
It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Pheromones have found wide application as pesticides and are used on cotton crops.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Amrutanjan Health Care Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Amrutanjan Health Care Ltd or Sanofi India Ltd?

Market cap of Amrutanjan Health Care Ltd is 1,607 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Amrutanjan Health Care Ltd and Sanofi India Ltd?

The stock performance of Amrutanjan Health Care Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amrutanjan Health Care Ltd and Sanofi India Ltd?

As of May 18, 2026, the Amrutanjan Health Care Ltd stock price is INR ₹556.05. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Amrutanjan Health Care Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Amrutanjan Health Care Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.